A Phase 1a/b Trial of Luxeptinib (CG-806) in Patients with Relapsed/Refractory B-Cell Malignancies or Acute Myeloid Leukemia and Evaluation of New G3 FormulationAaron D. Goldberg,Felipe Samaniego,Maro Ohanian,Paul B. Koller,Namrata Sonia Chandhok,Ahad A. Sadiq,Daruka Mahadevan,Mohamad A. Cherry,Jessica K. Altman,John M. Burke,Michael Z. Koontz,J. C. C. Villasboas,Ben K. Tomlinson,Laura E. Finn,Erin G. Reid,Jason Melear,Victor Priego,Patrick Cobb,Elizabeth Heritage,Paul Conkling,David Cosgrove,Lindsey E. Roeker,Eric Tam,Donna Nguyen Haney,Jia Hu, Ranjeet Sinha, Nawazish Khan,William G. Rice,Rafael BejarBLOOD（2023）引用 0|浏览43暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
